Results 21 to 30 of about 1,454,464 (291)

NPM1-Mutated Acute Myeloid Leukemia with Uterine Myeloid Sarcoma: A Diagnostic Challenge [PDF]

open access: yesDocumenta Haematologica
Introduction: Acute myeloid leukemia( AML) NPM1+ represents a distinct entity, frequently associated with normal cytogenetics and favorable prognosis in the absence of other adverse mutations.
Daiana TUNARU   +7 more
doaj   +1 more source

Essential requirements for setting up a stem cell processing laboratory [PDF]

open access: yes, 2014
The Graft Processing subcommittee of the Worldwide Network for Blood and Marrow Transplantation wrote this guideline to assist physicians and laboratory technologists with the setting up of a cell processing laboratory (CPL) to support a hematopoietic ...
Niederwieser, Dietger Walter   +9 more
core   +1 more source

Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature

open access: yesFrontiers in Oncology, 2022
Life expectancy of multiple myeloma (MM) patients has improved in last years due to the advent of anti-CD38 monoclonal antibodies in combination with immunomodulators and proteasome inhibitors.
Francesca Farina   +16 more
doaj   +1 more source

Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma [PDF]

open access: yes, 1991
The effect of murine cytomegalovirus on myelopoiesis was studied in long-term bone marrow culture to find an in vitro correlate for the lethal virus interference with bone marrow reconstitution (W. Mutter, M. J. Reddehase, F. W. Busch, H.-J. Bühring, and
Busch, Friedrich W.   +3 more
core   +1 more source

Karyotype abnormalities and their clinical significance in a group of chronic myeloid leukemia patients treated with hematopoietic stem cell transplantation

open access: yesSão Paulo Medical Journal
CONTEXT AND OBJECTIVE: Following hematopoietic stem cell transplantation (HSCT), karyotyping is a valuable tool for monitoring engraftment and disease status.
Luize Otero   +7 more
doaj   +1 more source

Post Autologous Stem Cell Transplantation Complication Management in Case of Malignant Lymphoma Patients

open access: yesJournal of Interdisciplinary Medicine, 2017
Introduction: Autologous hematopoietic stem cell transplantation (ASCT) represents a standard therapy in the management of hematologic malignancies such as malignant lymphomas and has used for approximately three decades.
Pakucs Annamária   +8 more
doaj   +1 more source

The Evolution of Intracardiac Hemodynamics Post Autologous Stem Cell Transplant in a Case of Multiple Myeloma Associated with Severe Tricuspid and Mitral Valve Insufficiency

open access: yesJournal of Interdisciplinary Medicine, 2017
Stem cells are undifferentiated cells that can divide and become differentiated. Hematopoietic stem cells cannot transform into new stem cells such as cardiomyocytes or new heart valves, but they act through paracrine effects, by secreting cytokines and ...
Tudor Cezara-Iuliana   +8 more
doaj   +1 more source

Differentiation of metastatic lesions to the bones and multiple myeloma – a case study

open access: yesJournal of Education, Health and Sport, 2020
Bones are one of the most common locations for cancer metastasis. Foci, which are in the most cases osteolytic, are located in the spine, ribs, pelvis, long bones.
Olaf Pachciński   +5 more
doaj   +1 more source

Infant Embryonal CNS Tumors: Molecular Insights and Treatment Considerations for Contemporary Pediatric Neuro‐Oncology

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Embryonal tumors comprise the majority of malignant central nervous system (CNS) neoplasms diagnosed in children under 3 years of age. Compared with their counterparts in older children, these tumors exhibit distinct molecular biology and a more aggressive clinical phenotype, while their management is complicated by the heightened ...
Sudarshawn Damodharan   +3 more
wiley   +1 more source

The role of bone marrow derived cells in cardiac repair [PDF]

open access: yes, 2012
PhDCurrent pharmacological therapies fail to address the final end-point of cardiac ischaemia — the death and dysfunction of cardiomyocytes. Advances in stem cell biology have provided hope, for the first time, of addressing this underlying pathology.
Lovell, Matthew J.
core   +4 more sources

Home - About - Disclaimer - Privacy